Newron Pharmaceuticals
NWRN.SW
#8290
Rank
C$0.22 B
Marketcap
$11.47
Share price
4.00%
Change (1 day)
50.29%
Change (1 year)

P/S ratio for Newron Pharmaceuticals (NWRN.SW)

P/S ratio at the end of 2023: 10.5

According to Newron Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -4.79. At the end of 2023 the company had a P/S ratio of 10.5.

P/S ratio history for Newron Pharmaceuticals from 2006 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202310.5129.1%
20224.58-5.53%
20214.85-27.95%
20206.73-54.65%
201914.8-32.87%
201822.167.79%
201713.2-76.3%
201655.6-60.74%
2015142-22.44%
2014183305.31%
201345.0430.01%
20128.50177.83%
20113.06-94.23%
201053.062.88%
200932.6123.09%
200814.6-66.81%
200744.0-72.9%
2006162